Evidence map›Paper›PMID 41803273›Full record

ReviewVirchows Archiv : an international journal of pathology2026

SMARCA4-deficient carcinoma of the head and neck region: report of 8 new sinonasal and non-sinonasal cases and literature review.

Mihaela Farkas, Abbas Agaimy, Marián Švajdler, Lukáš Hauer, Petr Martínek, Tomáš Vaněček, Kristýna Pivovarčíková, Barbora Prchlíková, Roderick H W Simpson, Klaudia Gočárová and 7 more

Abstract readReviewCase Reports
In one paragraph

Review in Virchows Archiv : an international journal of pathology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Mihaela FarkasOnco Team Diagnostic, Bucharest, Romania.
Abbas AgaimyComprehensive Cancer Center (CCC) Erlangen-EMN, Institute of Pathology, University Hospital Erlangen, Erlangen, Germany.
Marián ŠvajdlerDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, University Hospital Plzen, Dr. E. Benese 13, 305 99, Plzen, Czech Republic.
Lukáš HauerDepartment of Oral and Maxillofacial Surgery, Faculty of Medicine in Plzen, University Hospital and Faculty of Medicine in Pilsen, Charles University, Plzen, Czech Republic.
Petr MartínekBioptic Laboratory, Ltd, Plzen, Czech Republic.
Tomáš VaněčekBioptic Laboratory, Ltd, Plzen, Czech Republic.
Kristýna PivovarčíkováDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, University Hospital Plzen, Dr. E. Benese 13, 305 99, Plzen, Czech Republic.
Barbora PrchlíkováDepartment of Pathological Anatomy, Rudolf and Stefanie Hospital Benešov, Inc., Benešov, Czech Republic.
Roderick H W SimpsonDepartment of Pathology, University of Calgary, Calgary, AB, Canada.
Klaudia GočárováFaculty of Medicine, St. Elizabeth Cancer Institute, Ltd., 1 st Oncology Clinic, Comenius University in Bratislava, Bratislava, Slovakia.
Peter VerešMedicyt, s.r.o., Bratislava, Slovakia.
Petr SlavíkDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, University Hospital Plzen, Dr. E. Benese 13, 305 99, Plzen, Czech Republic.
Kristýna BehenskáDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, University Hospital Plzen, Dr. E. Benese 13, 305 99, Plzen, Czech Republic.
Ksenija MarjanovicFaculty of Medicine Osijek, Josip Juraj Strossmayer University of Osijek, Osijek, Croatia.
Michal MichalDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, University Hospital Plzen, Dr. E. Benese 13, 305 99, Plzen, Czech Republic.
Alena SkálováDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, University Hospital Plzen, Dr. E. Benese 13, 305 99, Plzen, Czech Republic.
Martina BradováDepartment of Pathology, Faculty of Medicine in Plzen, Charles University, University Hospital Plzen, Dr. E. Benese 13, 305 99, Plzen, Czech Republic. bradova@biopticka.cz.ORCID http://orcid.org/0000-0002-5829-5572

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Neoplasms with inactivating mutations in SWI/SNF chromatin remodeling complex subunits gained attention in the head and neck (H&N) region due to their poor clinical outcomes. The sinonasal tract is a recognized "hot-spot" for SMARCA4-deficient cancers, including SMARCA4-deficient sinonasal carcinomas, and most sinonasal teratocarcinosarcomas. To date, only two H&N SMARCA4-deficient carcinomas have been reported outside the sinonasal region. We identified eight cases of SMARCA4-deficient H&N carcinomas from the authors' files and reviewed their clinicopathological features. All cases with available tissue blocks were investigated by molecular genetic methods using next-generation sequencing (NGS). The cohort included four sinonasal and four non-sinonasal tumors involving the tongue, oral floor, the upper jaw submucosa, and the hypopharynx. The extra-sinonasal cases affected three males and one female (ages 61-81). Histologically, two cases showed poorly differentiated small cell morphology, one case resembled salivary duct carcinoma, and one case had a dedifferentiated squamous cell carcinoma phenotype. Regional lymph node metastases were documented in two cases. Sinonasal tumors showed spindle cell morphology, olfactory neuroblastoma-like features with glandular or squamoid differentiation areas, and an undifferentiated small cell pattern. This study expands the known anatomical distribution and histological spectrum of SMARCA4-deficient H&N carcinomas. Their occurrence outside the sinonasal tract is rare and poses a diagnostic challenge. These tumors are highly aggressive and often present at advanced stages. In the sinonasal region, they can mimic olfactory neuroblastoma, while in other H&N sites, they can resemble neuroendocrine carcinoma.

Indexed as

Biomarkers, TumorCarcinomaDNA HelicasesHead and Neck NeoplasmsNuclear ProteinsParanasal Sinus NeoplasmsTranscription FactorsAgedAged, 80 and overFemaleHumansMaleMiddle AgedMutationBiomarkers, TumorDNA HelicasesNuclear ProteinsSMARCA4 protein, humanTranscription FactorsNon-sinonasalOral cavitySinonasalSMARCA4-deficient carcinoma

Identifiers

PMID41803273
PMCPMC13176017

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.